Genomic profiles associated with early micrometastasis in lung cancer: Relevance of 4q deletion

Clinical Cancer Research

Volumn 15, Issue 5, 2009, Pages 1566-1574

  Wrage, Michaela ^a   Ruosaari, Salla ^e   Eijk, Paul P ^f   Kaifi, Jussuf T ^c   Hollmen, Jaakko ^d   Yekebas, Emre F ^c   Izbicki, Jakob R ^c   Brakenhoff, Ruud H ^f   Streichert, Thomas ^d   Riethdorf, Sabine ^a   Glatzel, Markus ^b   Ylstra, Bauke ^f   Pantel, Klaus ^a   Wikman, Harriet ^a,d  

^a Institute for Tumor Biology   (Germany)

^b Neuropathology and Department   (Germany)

^c Department of General Visceral and Thoracic Surgery ^*  (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e AALTO UNIVERSITY   (Finland)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN;

ADULT; AGED; ARTICLE; BONE MARROW; BRAIN METASTASIS; CANCER CELL; CANCER GENETICS; CHROMOSOME 10P; CHROMOSOME 10Q; CHROMOSOME 17Q; CHROMOSOME 20Q; CHROMOSOME 4Q; CHROMOSOME DELETION 4; CHROMOSOME LOSS; CHROMOSOME SIZE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DISSEMINATED CANCER; DNA MICROARRAY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION PROFILING; GENE NUMBER; GENETIC ASSOCIATION; GENOMICS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CARCINOMA, LARGE CELL; CARCINOMA, SQUAMOUS CELL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 4; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SMALL CELL LUNG CARCINOMA;

EID: 63449140725     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-2188     Document Type: Article

References (39)

1. Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol 2005;40:90-7.
2. Pantel K, Izbicki J, Passlick B, et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 1996;347: 649-53.
3. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004;4:448-56.
4. Cote RJ, Beattie EJ, Chaiwun B, et al. Detection of occult bone marrow micrometastases in patients with operable lung carcinoma. Ann Surg 1995;222: 415-23; discussion 23-5.
5. Kubuschok B, Passlick B, Izbicki JR, Thetter O, Pantel K. Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non- small-cell lung cancer. J Clin Oncol 1999;17:19-24.
6. Naume B, Zhao X, Synnestvedt M, et al.Presenceof bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer. Mol Oncol 2007;1:160-71.
7. Woelfle U, Cloos J, Sauter G, et al. Molecular signature associated with bone marrow micrometastasis in human breast cancer. Cancer Res 2003;63:5679-84.
8. Bubendorf L, Muller P, Joos L, et al. Multitarget FISH analysis in the diagnosis of lung cancer. Am J Clin Pathol 2005;123:516-23.
9. Halling KC, Rickman OB, Kipp BR, Harwood AR, Doerr CH, Jett JR. A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens. Chest 2006;130: 694-701.
10. Braun S, Pantel K, Muller P, et al. Cytokeratin- positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000;342:525-33.
11. Pantel K, Schlimok G, Angstwurm M, et al. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 1994;3:165-73.
12. Bauer KD, de laTorre-Bueno J, Diel IJ, et al. Reliable and sensitive analysis of occult bone marrow metastases using automated cellular imaging. Clin Cancer Res 2000;6:3552-9.
13. van den Ijssel P, Tijssen M, Chin SF, et al. Human and mouse oligonucleotide-based array CGH. Nucleic Acids Res 2005;33:e192.
14. Ruosaari S, Hollmén J. Image analysis for detecting faulty spots from microarray images. Lecture Notes Comput Sci 2002;2534:259-66.
15. Nymark P, Wikman H, Ruosaari S, et al. Identification of specific gene copy number changes in asbestosrelated lung cancer. Cancer Res 2006;66:5737-43.
16. Jong K, Marchiori E, Meijer G, Vaart AV, Ylstra B. Breakpoint identification and smoothing ofarraycomparative genomic hybridization data. Bioinformatics 2004;20:3636-7.
17. Kettunen E, Anttila S, Seppanen JK, et al. Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer. Cancer Genet Cytogenet 2004;149:98-106.
18. Swets JA. Measuring the accuracy of diagnostic systems. Science 1988;240:1285-93.
19. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95: 14863-8.
20. Dennis G, Jr., Sherman BT, Hosack DA, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003;4:P3.
21. Wikman H, Nymark P, Vayrynen A, et al. CDK4 is a probable target gene in a novel amplicon at 12q13.3- q14.1 in lung cancer. Genes Chromosomes Cancer 2005;42:193-9.
22. Balsara BR, Testa JR. Chromosomal imbalances in human lung cancer. Oncogene 2002;21:6877-83.
23. Wikman H, Ruosaari S, Nymark P, et al. Gene expression and copy number profiling suggests the importance of allelic imbalance in 19p in asbestos- associated lung cancer. Oncogene 2007;26: 4730-37.
24. Albertson DG, Pinkel D. Genomic microarrays in human genetic disease and cancer. Hum Mol Genet 2003;12:145R-52.
25. Knuutila S, Autio K, Aalto Y Online access to CGH data of DNA sequence copy number changes. Am J Pathol 2000;157:689.
26. Sy SM-H, Wong N, Lee T-W, et al. Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung. Eur J Cancer 2004; 40:1082-94.
27. Yakut T, Schulten HJ, Demir A, et al. Assessment of molecular events in squamous and non-squamous cell lung carcinoma. Lung Cancer 2006;54:293-301.
28. Pollack JR. Chromosome instability leaves its mark. Nat Genet 2006;38:973-4.
29. Carter SL, Eklund AC, KohaneI S, Harris LN, Szallasi Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 2006;38: 1043-8.
30. Goeze A, Schluns K, Wolf G, Thasler Z, Petersen S, Petersen I. Chromosomal imbalances of primary and metastatic lung adenocarcinomas. J Pathol 2002; 196:8-16.
31. Bando K, Nagai H, MatsumotoS, et al. Identification of a1-cM region of common deletion on 4q35associated with progression of hepatocellular carcinoma. Genes Chromosomes Cancer 1999;25:284-9.
32. Lin SC, Chen YJ, Kao SY, et al. Chromosomal changes in betel-associated oral squamous cell carcinomas and their relationship to clinical parameters. Oral Oncol 2002;38:266-73.
33. Petersen I, Hidalgo A, Petersen S, et al. Chromosomal imbalances in brain metastases of solid tumors. Brain Pathol 2000;10:395-401.
34. Cho ES, Chang J, Chung KY, Shin DH, Kim YS, Kim SK. Identification of tumor suppressor loci on the long arm of chromosome 4 in primary small cell lung cancers. Yonsei Med J 2002;43:145-51.
35. Shivapurkar N, Virmani AK, Wistuba II, et al. Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma. Clin Cancer Res 1999;5:17-23.
36. Sterian A, KanT, Berki AT, et al. Mutational and LOH analyses of the chromosome 4q region in esophageal adenocarcinoma. Oncology 2006;70:168-72.
37. Kim YH, Girard L, Giacomini CP, et al. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification. Oncogene 2006;25:130-8.
38. Vaidya KS, Welch DR. Metastasis suppressors and their roles in breast carcinoma. J Mammary Gland Biol Neoplasia 2007;12:175-90.
39. Berger JC, Vander Griend DJ, Robinson VL, Hickson JA, Rinker-Schaeffer CW. Metastasis suppressor genes: from gene identification to protein function and regulation. Cancer Biol Ther 2005;4:805-12.